Dowling & Yahnke’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$13.4M Hold
302,571
0.62% 36
2022
Q2
$11.2M Hold
302,571
0.53% 40
2022
Q1
$11.2M Buy
302,571
+150
+0% +$5.56K 0.49% 52
2021
Q4
$9.2M Sell
302,421
-100
-0% -$3.04K 0.44% 70
2021
Q3
$10.1M Sell
302,521
-629
-0.2% -$21.1K 0.56% 46
2021
Q2
$12.1M Sell
303,150
-70
-0% -$2.79K 0.69% 34
2021
Q1
$13.6M Sell
303,220
-172,241
-36% -$7.74M 0.93% 25
2020
Q4
$26.9M Sell
475,461
-100,017
-17% -$5.66M 1.92% 7
2020
Q3
$27.3M Sell
575,478
-100,000
-15% -$4.74M 2.19% 7
2020
Q2
$39.8M Hold
675,478
3.34% 4
2020
Q1
$31.9M Hold
675,478
3.08% 4
2019
Q4
$40.8M Hold
675,478
3.13% 4
2019
Q3
$40.5M Hold
675,478
3.35% 4
2019
Q2
$43.4M Hold
675,478
3.6% 1
2019
Q1
$54.8M Hold
675,478
5.27% 1
2018
Q4
$39.4M Hold
675,478
4.08% 2
2018
Q3
$34.8M Buy
675,478
+17
+0% +$877 3.04% 4
2018
Q2
$28.1M Sell
675,461
-500
-0.1% -$20.8K 2.61% 4
2018
Q1
$29.8M Buy
675,961
+70
+0% +$3.09K 2.79% 4
2017
Q4
$34M Hold
675,891
3.07% 4
2017
Q3
$34.3M Hold
675,891
3.48% 3
2017
Q2
$34.4M Buy
675,891
+48
+0% +$2.44K 3.62% 3
2017
Q1
$27.2M Hold
675,843
2.89% 3
2016
Q4
$32.3M Sell
675,843
-629
-0.1% -$30.1K 3.62% 3
2016
Q3
$24.8M Buy
676,472
+174
+0% +$6.38K 2.9% 4
2016
Q2
$15.8M Sell
676,298
-41
-0% -$955 1.89% 4
2016
Q1
$27.4M Sell
676,339
-40
-0% -$1.62K 3.38% 3
2015
Q4
$41.9M Hold
676,379
5.27% 1
2015
Q3
$27.3M Buy
676,379
+29
+0% +$1.17K 3.72% 3
2015
Q2
$38.9M Buy
676,350
+27
+0% +$1.55K 4.9% 2
2015
Q1
$43.1M Buy
676,323
+10
+0% +$637 5.38% 1
2014
Q4
$41.8M Buy
676,313
+15
+0% +$926 5.2% 2
2014
Q3
$26.3M Hold
676,298
3.46% 3
2014
Q2
$23.3M Hold
676,298
3.01% 3
2014
Q1
$29.2M Buy
676,298
+500
+0.1% +$21.6K 3.85% 3
2013
Q4
$26.9M Hold
675,798
3.79% 2
2013
Q3
$25.4M Sell
675,798
-100,000
-13% -$3.75M 3.97% 2
2013
Q2
$20.8M Buy
+775,798
New +$20.8M 3.47% 2